Pascal Deschatelets

2021

In 2021, Pascal Deschatelets earned a total compensation of $2.6M as Chief Scientific Officer at Apellis Pharmaceuticals, a 9% decrease compared to previous year.

Compensation breakdown

Bonus$158,400
Option Awards$1,617,188
Salary$438,269
Stock Awards$420,938
Other$13,180
Total$2,647,975

Deschatelets received $1.6M in option awards, accounting for 61% of the total pay in 2021.

Deschatelets also received $158.4K in bonus, $438.3K in salary, $420.9K in stock awards and $13.2K in other compensation.

Rankings

In 2021, Pascal Deschatelets' compensation ranked 4,925th out of 12,415 executives tracked by ExecPay. In other words, Deschatelets earned more than 60.3% of executives.

ClassificationRankingPercentile
All
4,925
out of 12,415
60th
Division
Manufacturing
2,061
out of 5,508
63rd
Major group
Chemicals And Allied Products
873
out of 2,378
63rd
Industry group
Drugs
782
out of 2,099
63rd
Industry
Pharmaceutical Preparations
557
out of 1,549
64th

Pay ratio

Pascal Deschatelets' Pay$2,647,975
Median Employee's Pay$321,867
Pay Ratio

8

to 1

In 2021, the annual total compensation of Pascal Deschatelets was $2,647,975.

The annual total compensation of the median employee at Apellis Pharmaceuticals was $321,867.

The ratio of Pascal Deschatelets' pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 20, 2022.

Deschatelets' colleagues

We found four more compensation records of executives who worked with Pascal Deschatelets at Apellis Pharmaceuticals in 2021.

2021

Cedric Francois

Apellis Pharmaceuticals

Chief Executive Officer

2021

Timothy Sullivan

Apellis Pharmaceuticals

Chief Financial Officer

2021

Adam Townsend

Apellis Pharmaceuticals

Chief Commercial Officer

2021

Federico Grossi

Apellis Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like